Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Scientific Oncology Center is a Kazakhstan-based oncology hospital and research center in Astana focused on cancer diagnosis, treatment, nuclear medicine, radiation oncology, proton therapy, and translational research. The institution operates as an active healthcare provider rather than a venture-backed drug-development biotech company, and its services include outpatient and inpatient oncology care, radiology, radionuclide diagnostics and therapy, bone marrow transplantation, and educational programs. The center was created as a national flagship oncology complex and opened its new major facility in April 2025. It is equipped with advanced systems for proton therapy, PET imaging, radiation therapy, and cyclotron-based radiopharmaceutical production, positioning it as a major cancer care hub for Kazakhstan and Central Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Scientific Oncology Center.